The study of thyroid profile in abnormal uterine bleeding at tertiary care center, Rajasthan, India
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20192444Keywords:
Abnormal uterine bleeding, Hypothyroidism, Hyperthyroidism, Menorrhagia, OligomenorrhoeaAbstract
Background: Hypothyroidism and Hyperthyroidism leads to menstrual irregularities. Females with thyroid gland abnormality have chances of reproductive abnormalities ranging from abnormal sexual development, menstrual irregularities, infertility and premature menopause. The objectives were to study the association between thyroid dysfunction and AUB in the reproductive age group (18-45 years), To study the thyroid abnormalities in different types of AUB in the reproductive age group, to establish if screening for thyroid abnormalities is justified using T3, T4 and TSH.
Methods: This cross-sectional study conducted among 250 women with ‘abnormal uterine bleeding’ (AUB). Inclusion criteria for participants were females in the age group of 18-45 years, females presenting with abnormal uterine bleeding, with thyroid dysfunction, females who do not have signs of demonstrable pelvic pathologyincluding PID.
Results: Majority of the patients belonged to the age group of 24 - 32 years i.e.56.8%, 9.2% cases were nullipara, 44.0% cases have menorrhagia, 32.2% have oliogomennorrhea, 19.6% have amenorrhea. Around 3.6% had Thyromegaly, 12.4% have weight gain in hypothyroidism, 28.4% have fatigue in hyperthyroidism, 6.8% cases have higher T4 level, 18.0% cases have higher TSH level.
Conclusions: The risk of progression to overt hypothyroidism (about 5% per year) in patients with subclinical disease and the cost-benefit ratio also emphasises the need for selective screening. Early detection of subclinical disease by selective screening facilitates appropriate therapy early in the course of the disease.
References
Olive D, Palter S. Reproductive Physiology.In: Berek J.S, eds. Berek and Novak’s Gynaecology.14 th ed Philadelphia: Lippincott Williams and Wilkins Company; 2002:161-186.
Gollakota S, Nirmala CH, Naga AM. Study of Thyroid Profile in women with Abnormal Uterine Bleeding. IOSR J Dent Med Scien. 2017;16(10):53-6.
Thomas R. Reid RL. Thyroid diseases and reproductive dysfunction. Obstet Gynaecol. 1987;70:789-98.
Mazzaferri EL. Evaluation and management of thyroid disorders in women. Am J Obstet Gynaecol. 1997;176(3):144-9.
Kochupillai N. Clinical Endocrinology in India. Curr Sci. 2000;79:1061-7.
Hollowell JG, Staehling NW, Flanders WD. Serum T.S.H. T4 and Thyroid antibodies in the United States population. (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002;87(2):489-99.
Longcope C, Abend S, Braverman LE, Emerson CH. Androstenedione and estrone dynamics in hypothyroid women. J Clin Endocrinol Metabol. 1990;70:903-7.
Scanlon MF, Chan V, Heath M, Pourmand M., Rodriguez-Arnao MD, Weightman DR, et al. and Hall R. Dopaminergic control of thyrotropin, alpha-subunit, thyrotropin beta-subunit, and prolactin in euthyroidism and hypothyroidism: dissociated responses to dopamine receptor blockade with metoclopramide in hypothyroid subjects. J Clin Endocrinol Metabo. 1981;53:360-5.
Thomas R, Reid RL. Thyroid disease and reproductive dysfunction: a review. Obstet Gynecol. 1987;70:789-98.
Wakim AN. Polizotto SL, Buffo MJ, Marrero MA. Burholt DR. Thyroid hormones in human follicular fluid and thyroid hormone receptors in human granulosa cells. Fertility and Sterility. 1993;59:1187-90.
Cecconi S, Rucci N, Scaldaferri ML, Masciulli MP, Rossi G, Moretti C, et al. Thyroid hormone effects on mouse oocyte maturation and granulosa cell aromatase activity. Endocrinolo. 1999;140:1783-8.
Maruo T, Matsuo H, Mochizuki M. Thyroid hormone as a biological amplifier of differentiate dtrophoblast function in early pregnancy. Acta Endocrinol. 1991;125:58-66.
Ansell JE. The blood in the hypothyroidism. In: L. Braverman, R. Utiger eds. Werner and Ingbar's theThyroid: A Fundamental and Clinical Text. 7th Ed. Philadelphia: Lippincott-Raven; 1996:821-825.
Gowri M, Radhika BH, Harshini V, Ramaiaha R. Role of thyroid function tests in women with abnormal uterine bleeding. Int J Reprod Contracept Obstet Gynecol. 2014;3:54-7.
Jinger SK, Verma A, Dayma I, Talreja T. To study the thyroid profile in menstrual disorder at tertiary care hospital in northern western Rajasthan, India. Int J Res Med Sci. 2017;5:2212-4.
Komathi R, Mallika A. A study of thyroid profile in abnormal uterine bleeding (aub) among reproductive age group women. Int J Current Med Scie. 2016;6(7):133-6.
Usharani N, Shavi K. Clinical study of hypo/hyper thyroidism in dysfunctional uterine bleeding. Int J Reprod Contracept Obstet Gynecol. 2017;6:3324-7.
Ali J, Das KK, Konyak P. Study of relation of thyroid profile with abnormal uterine bleeding. Sch J App Med Sci. 2015;3:2688-92.
Panda A, Parulekar SV, Gupta A. Diagnostic hysteroscopy in abnormal uterine bleeding and histopathological correlation. J Obstet Gynaecol India. 1999;49:74-6.
Pennant ME, Mehta R, Moody P, Hackett G, Prentice A, Sharp SJ. Premenopausal abnormal uterine bleeding and risk of endometrial cancer. BJOG. 2017;124:404-11.
Wilansky DL, Grisesman B. Early hypothyroidism in patients with menorrhagia. Am J Obstet Gynaecol. 1990;163(2):697.
Estrada JM, Soldin D, Buckey TM, Burman KD, Soldin OP. Thyrotropin Isoforms: Implications for Thyrotropin Analysis and Clinical Practice. Thyroid. 2014 Mar 1; 24(3): 411-23.
